Replies to post #14856 on Value Microcaps Motherboard

[micham2012]

bbotcs re VPHM:

Don't know about you, but it's my day job.

The company needs to be very careful here. As Bobwins has pointed out, a major factor in the Monte Carlo simulation, and thus in the size of the charge to earnings that will occur in Q2, is the price of the stock on June 30. To give even a range of what that charge is likely to be, some assumption must be made about the stock price at the close on June 30. With all the conversion shares that are out there right now, including the autoconverts, there is a decent chance that the stock will experience extremely heavy selling pressure during the next 3 days. I find it hard to fault those on the call for not hazarding a guess about the number.

I do wish that the company had reported today on Vancocin sales for the quarter -- at least the results for the first 2 months of the quarter. These numbers must be known (or knowable) by now. Everything that was said on the call about Vancocin demand was positive -- extra hospitals, no evidence of seasonality, etc. -- but I didn't hear any concrete numbers.

All in all, though, an encouraging and reassuring call. I am very impressed with how this whole thing has been orchestrated, and with management generally.

Steve